AQP5 and Patent ductus arteriosus: AQP3 expression increased along the development of PDA, from the early to later stages of disease, while AQP5 was increased in the early stages and almost undetectable in later stages, suggesting AQP5 as a promising biomarker for PDA early diagnosis.